Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384628 | SCV001584199 | pathogenic | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr490Leufs*5) in the CERKL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CERKL are known to be pathogenic (PMID: 14681825, 23591405, 24043777). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CERKL-related conditions. ClinVar contains an entry for this variant (Variation ID: 1072011). For these reasons, this variant has been classified as Pathogenic. |
Ophthalmic Genetics Group, |
RCV003324564 | SCV004030370 | pathogenic | Retinitis pigmentosa | 2023-07-24 | criteria provided, single submitter | research | Clinical significance based on ACMG v2.0 |
Baylor Genetics | RCV003469706 | SCV004216795 | likely pathogenic | Retinitis pigmentosa 26 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003469706 | SCV005655321 | likely pathogenic | Retinitis pigmentosa 26 | 2024-04-15 | criteria provided, single submitter | clinical testing |